HIV Citation List: November 11 - November 24, 2009

Pubmed citations:

1. Efficacy and safety of TMC278 in antiretroviral-naive HIV-1 patients: week 96 results of a phase IIb randomized trial. Pozniak AL, Morales-Ramirez J, Katabira E, Steyn D, Lupo SH, Santoscoy M, Grinsztejn B, Ruxrungtham K, Rimsky LT, Vanveggel S, Boven K; on behalf of the TMC278-C204 study group. AIDS. 2009 Nov 18. [Epub ahead of print]PMID: 19926964

2. Hypothesis of snake and insect venoms against Human Immunodeficiency Virus: a review. Meenakshisundaram R, Sweni S, Thirumalaikolundusubramanian P. AIDS Res Ther. 2009 Nov 19;6(1):25. [Epub ahead of print]PMID: 19922674

3. Diketopiperazines from the Cordyceps-Colonizing Fungus Epicoccum nigrum. Guo H, Sun B, Gao H, Chen X, Liu S, Yao X, Liu X, Che Y. J Nat Prod. 2009 Nov 17. [Epub ahead of print]PMID: 19919067

4. Peptide inhibitors of HIV-1 integrase: from mechanistic studies to improved lead compounds. Maes M, Levin A, Hayouka Z, Shalev DE, Loyter A, Friedler A. Bioorg Med Chem. 2009 Nov 15;17(22):7635-42. Epub 2009 Oct 4.PMID: 19850483

5. An antibody-recruiting small molecule that targets HIV gp120. Parker CG, Domaoal RA, Anderson KS, Spiegel DA. J Am Chem Soc. 2009 Nov 18;131(45):16392-4.PMID: 19839582

6. Synthesis and biological evaluation of novel 2-(substituted phenylaminocarbonylmethylthio)-6-(2,6-dichlorobenzyl)-pyrimidin-4(3H)-ones as potent HIV-1 NNRTIs. Yu M, Liu X, Li Z, Liu S, Pannecouque C, Clercq ED. Bioorg Med Chem. 2009 Nov 15;17(22):7749-54. Epub 2009 Sep 24.PMID: 19819705

7. Chemical Library Screens Targeting an HIV-1 Accessory Factor/Host Cell Kinase Complex Identify Novel Antiretroviral Compounds. Emert-Sedlak L, Kodama T, Lerner EC, Dai W, Foster C, Day BW, Lazo JS, Smithgall TE. ACS Chem Biol. 2009 Nov 20;4(11):939-947.PMID: 19807124

ISI Web of Knowledge citations:

8. Isolation and Characterization of a Trypsin Inhibitor and a Lectin from Glycine max cv. Large Black Soybean. Xiu, JY; Tzi, BN. FOOD SCIENCE AND BIOTECHNOLOGY, 2009; 18(5): 1173-1179.

9. Bioorganic synthesis of a recombinant HIV-1 fusion inhibitor, SC35EK, with an N-terminal pyroglutamate capping group. Kajiwara, K; Watanabe, K; Tokiwa, R; Kurose, T; Ohno, H; Tsutsumi, H; Hata, Y; Izumi, K; Kodama, E; Matsuoka, M; Oishi, S; Fujii, N. BIOORGANIC & MEDICINAL CHEMISTRY, 2009; 17(23): 7964-7970.